Marshall Wace, LLP Novo Nordisk A S Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Marshall Wace, LLP holds 2,000 shares of NVO stock, worth $285,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,000

Previous 233,879 99.14%

Holding current value

$285,480

Previous $24.2 Million 98.94%

% of portfolio

0.0%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $23.7 Million - $31.5 Million	-231,879 Reduced 99.14%	2,000 $256,000
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $20.5 Million - $24.7 Million	233,879 New	233,879 $24.2 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $12.8 Million - $14.2 Million	82,160 Added 258.72%	113,916 $18.4 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $4.2 Million - $5.05 Million	31,756 New	31,756 $5.05 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $1.1 Million - $1.36 Million	11,592 New	11,592 $1.16 Million

Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $378,477 - $446,555	-3,666 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $81,276 - $98,247	-873 Reduced 19.23%	3,666 $407,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $832,526 - $1.02 Million	-8,683 Reduced 65.67%	4,539 $508,000
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $1.12 Million - $1.41 Million	13,222 New	13,222 $1.27 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $1.11 Million - $1.26 Million	-16,623 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $1.96 Million - $2.26 Million	-30,618 Reduced 64.81%	16,623 $1.16 Million
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $3.01 Million - $3.32 Million	47,241 New	47,241 $3.28 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $47,593 - $55,235	-813 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $40,210 - $52,666	813 New	813 $49,000

Others Institutions Holding NVO

# of Institutions

1,854

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $322B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Novo Nordisk A S Transaction History